Immune context governs stage-specific responses to depleting anti-PD-1 antibody in type 1 diabetes
Cell Biomaterials · 2026-05 · 100490
DOI: 10.1016/j.celbio.2026.100490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biomaterials, 2026-05. Verfasst von Yujia Zhai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, The University of Utah.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA.
- Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA.
- Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.
- Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
- Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N6A 5C1, Canada.
- Lead contact.
Förderung
- NIAID NIH HHS
- NIBIB NIH HHS
- The University of Utah
- National Multiple Sclerosis Society
- National Institutes of Health
Zitieren
APA
Zhai, Y., Dong, S., Naatz, L. C., Zhang, T., Ye, X., Tantin, D. R., Andrews, T., & Chen, M. (2026). Immune context governs stage-specific responses to depleting anti-PD-1 antibody in type 1 diabetes. Cell Biomaterials, 100490. https://doi.org/10.1016/j.celbio.2026.100490
Vancouver
Zhai Y, Dong S, Naatz LC, Zhang T, Ye X, Tantin DR, et al. Immune context governs stage-specific responses to depleting anti-PD-1 antibody in type 1 diabetes. Cell Biomaterials. 2026:100490. doi:10.1016/j.celbio.2026.100490
BibTeX
@article{Zhai2026,
author = {Zhai, Yujia and Dong, Shuyun and Naatz, Lauren C and Zhang, Tianxiao and Ye, Xiangyang and Tantin, Dean R and Andrews, Tallulah and Chen, Mingnan},
title = {Immune context governs stage-specific responses to depleting anti-PD-1 antibody in type 1 diabetes},
journal = {Cell Biomaterials},
year = {2026},
pages = {100490},
doi = {10.1016/j.celbio.2026.100490}
}
EUVIMED